Bupropion HCl

DRUG3 trials

Sponsors

Centre for Addiction and Mental Health, Teva Pharmaceuticals USA, University of Minnesota

Conditions

Cigarette SmokingDepressive DisorderNicotine AddictionSchizophreniaSmoking Cessation

Phase 1

Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions

TerminatedNCT01046214

Teva Pharmaceuticals USADepressive Disorder

Start: 2010-01-31Updated: 2015-11-20

Phase 2

Varenicline and Smoking Cessation in Schizophrenia

CompletedNCT01111149

University of MinnesotaSchizophrenia, Smoking Cessation

Start: 2009-12-31End: 2012-08-31Updated: 2014-07-17

Phase 4

STOP Study: Effectiveness of Zyban in a Clinical Population

CompletedNCT01015170

Centre for Addiction and Mental HealthCigarette Smoking, Nicotine Addiction, Smoking Cessation

Start: 2009-10-31End: 2015-10-31Updated: 2017-03-27